These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 18794856)

  • 21. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
    Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
    J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
    Núñez M; Saran AM; Freedman BI
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
    Freedman BI; Edberg JC; Comeau ME; Murea M; Bowden DW; Divers J; Alarcón GS; Brown EE; McGwin G; Kopp JB; Winkler CA; Nelson GW; Illei G; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Langefeld CD; Kimberly RP;
    Am J Nephrol; 2010; 32(1):66-72. PubMed ID: 20523037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NPHS2 variation in sporadic focal segmental glomerulosclerosis.
    McKenzie LM; Hendrickson SL; Briggs WA; Dart RA; Korbet SM; Mokrzycki MH; Kimmel PL; Ahuja TS; Berns JS; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Cho M; Zhou YC; Binns-Roemer E; Kirk GD; Kopp JB; Winkler CA
    J Am Soc Nephrol; 2007 Nov; 18(11):2987-95. PubMed ID: 17942957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility genes in common complex kidney disease.
    Divers J; Freedman BI
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):79-84. PubMed ID: 19838113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of MYH9-associated nephropathy.
    Bostrom MA; Freedman BI
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1107-13. PubMed ID: 20299374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.
    Johnstone DB; Zhang J; George B; Léon C; Gachet C; Wong H; Parekh R; Holzman LB
    Mol Cell Biol; 2011 May; 31(10):2162-70. PubMed ID: 21402784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
    Lin CP; Adrianto I; Lessard CJ; Kelly JA; Kaufman KM; Guthridge JM; Freedman BI; Anaya JM; Alarcón-Riquelme ME; ; Pons-Estel BA; Martin J; Glenn S; Adler A; Bae SC; Park SY; Bang SY; Song YW; Boackle SA; Brown EE; Edberg JC; Alarcón GS; Petri MA; Criswell LA; Ramsey-Goldman R; Reveille JD; Vila LM; Gilkeson GS; Kamen DL; Ziegler J; Jacob CO; Rasmussen A; James JA; Kimberly RP; Merrill JT; Niewold TB; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Moser KL; Harley JB; Gaffney PM; Montgomery CG
    Genes Immun; 2012 Apr; 13(3):232-8. PubMed ID: 22189356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension-associated kidney disease: perhaps no more.
    Freedman BI; Sedor JR
    J Am Soc Nephrol; 2008 Nov; 19(11):2047-51. PubMed ID: 18923054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.
    Franceschini N; Voruganti VS; Haack K; Almasy L; Laston S; Goring HH; Umans JG; Lee ET; Best LG; Fabsitz RR; MacCluer JW; Howard BV; North KE; Cole SA
    Hum Genet; 2010 Mar; 127(3):295-301. PubMed ID: 19921264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy.
    Johnstone DB; Ikizler O; Zhang J; Holzman LB
    PLoS One; 2013; 8(7):e67839. PubMed ID: 23874454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
    Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS
    Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
    O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
    Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31.
    Tsukaguchi H; Yager H; Dawborn J; Jost L; Cohlmia J; Abreu PF; Pereira AB; Pollak MR
    J Am Soc Nephrol; 2000 Sep; 11(9):1674-1680. PubMed ID: 10966492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.